Educational research & price index · Independent Janoshik & MZ Biolabs COA verification
Guide|20 CitationsLongevity & CellularFemale-friendly

Epitalon Dosing Protocol: Longevity Research Guide

Also known as: Epithalon, AEDG Tetrapeptide, Ala-Glu-Asp-Gly, Pineal Telomerase Peptide

Dose Range
10 mcgResearch range
0Typical research window: 10 mcg50 mcg

Studied in published research — not a medical recommendation. Primary protocol (Longevity Study): 10 μg, Daily.

Protocol at a Glance
How Often
Daily

Daily

A Typical Run
15 days

Showed increased lifespan in animal models

How It's Taken
Vial

Subcutaneous

Evidence
Clinical Trials

Published peer-reviewed research & clinical protocols

Half-Life & 72-Hour Clearance Shape
Not established

No verified human half-life on file for this compound

0h18h36h54h72h
On Your SyringeU-100 Insulin Syringe

A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.

5 mg vial · 2 mL water · 0.3 mL syringe
Concentration: 2.5 mg in every mL (25 mcg per unit)
0u6u12u18u24u30u
Low end: 10 mcg0.4 units

All U-100: 100 units = 1 mL. 500 doses in the vial at the low end.

Track the doses you run

Save Epitalon (Epithalon) to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.

Verified Peptide Vial Suppliers · Sorted by Real $/mg•Checked Nov 11, 2026

Epitalon (Epithalon) supplier & $/mg comparison.

Source:
Max $/mg:
Sort:
Swift Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$98.99
50mg vial
$1.98/mg
Bulletproof BioLabs
ILS Laboratories HPLC COA COA-2026-FXBTFU, lot BPB-2610-001
US Domestic Vial
Vendor-supplied list price (Nov 7, 2026; store requires login)
$105.00
50mg vial
$2.10/mg
Ascension Peptides50% OFF AUTO-APPLIED
Batch COAs (Kovera Labs, MZ Biolabs) on product page
US Domestic Vial
50% Off First Order Link
$25.00 net$50.00
10mg Lyophilized Vial
$2.50/mg$5.00/mg retail
Polaris Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$125.00
50mg vial
$2.50/mg
Core Peptides
COA per store product page
US Domestic Vial
List price (verified Oct 31)
$90.00
25mg vial
$3.60/mg
Biotech Peptides
COA per store product page
US Domestic Vial
List price (verified Oct 31)
$94.00
25mg vial
$3.76/mg
Elite Research USA
Batch COA on product page
US Domestic Vial
List price
$38.00
10mg vial
$3.80/mg
Pure Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026); code PEPTIDE9544 takes 10% off at checkout
$40.00
10mg vial
$4.00/mg
BioLongevity Labs
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$94.97
20mg vial
$4.75/mg
Limitless Peptides
COA per store product page
US Domestic Vial
Code: PEPTIDEPROTOCOLS
$75.00
10mg vial
$7.50/mg
Sorted strictly by calculated $/mg or 2026 COA score. Only research peptide vial suppliers are included in $/mg benchmarks.
Full Verified $/mg Index →

At a Glance · 2026 FDA / 503A / WADA / Evidence Profile

2026 FDA 503A Cat-2 UpdateTier 2 — Human Phase 1/2 Clinical Data
Pharmacological Class
Khavinson Short-Chain Epigenetic Organ Bioregulator Peptide (2–4 AA)
Administration Route
Under-the-skin injection (Subcutaneous)
2026 FDA & 503A Status
Not FDA-approved. In April 2026, the FDA removed 14 peptides (including BPC-157, Thymosin Beta-4/TB-500, CJC-1295, Ipamorelin, AOD-9604, Semax, Selank, and DSIP) from the Category 2 503A Interim Bulks List pending formal July 2026 PCAC rulemaking. Available as COA-verified research reference standards or via specialized physician telehealth guidance.
WADA Sport Status
Prohibited at All Times (WADA S0 Unapproved Substances & S2.2 Peptide Hormones, Growth Factors & Mimetics)
Evidence Tier
Tier 2 — Human Phase 1/2 Clinical Data: Published human Phase 1/2 clinical studies, regional regulatory approval, or controlled human biomarker trials
What is a Bioregulator?

A short peptide (typically 2-4 amino acids) that regulates the function of a specific organ or system. Developed by Russian scientist Vladimir Khavinson through decades of research. Examples include Epithalon (pineal gland), Thymalin (thymus/immune), and Vilon (immune system). Bioregulators are a subset of peptides.

Bottom Line Up Front

Epitalon (Epithalon) is a synthetic version of epithalamin, a pineal gland peptide. It activates telomerase and may lengthen telomeres. Developed by Russian scientist Vladimir Khavinson. Most evidence is from cell culture and animal studies.

Best evidence for

Telomere lengthening (in vitro), pineal function

Weakest evidence for

Human longevity, significant life extension

Pharma equivalent

None

Studies on file

20 (10 human)

EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. Epitalon (Epithalon) is not FDA approved for human use (unless specified above). This information does not constitute medical advice.

Overview

Epitalon is a synthetic tetrapeptide that mimics the natural pineal gland peptide epithalamin. Research has focused on its potential effects on telomerase activity, cellular aging, and circadian rhythm regulation.

Mechanisms of Action

  • Activates telomerase enzyme
  • May lengthen telomeres
  • Regulates melatonin production
  • Influences gene expression related to aging

Research Protocols

Summaries of published research. For educational purposes only.

Protocol NameSourceDoseFrequencyDurationRouteEvidenceLinkSave
Longevity Study
animal study
10 μgDaily15 daysSubcutaneousanimal
Telomere Extension Protocol
reported protocol
5-10 mgDaily for 10 days10 days, repeat every 6 monthsSubcutaneoushuman
Baseline & Mid-Cycle Biomarker Bloodwork Panel

Systemic Inflammation, Tissue Repair & Immune Biomarker Panel (Epitalon (Epithalon))

Objective inflammatory, hematologic, and trace-mineral markers to quantify connective-tissue recovery, cytokine resolution, and organ safety.

Draw fasted morning labs at Baseline (Day 0) and Mid-Cycle (Week 6–8)

hs-CRP (High-Sensitivity C-Reactive Protein)

Day 0 + Wk 6–8

Why track at baseline: Quantifies baseline systemic IL-6/NF-κB inflammatory burden from tendon, joint, gut, or vascular injury.

Week 6–8 check: Target <1.0 mg/L (optimal <0.5 mg/L) by Week 6–8 as tissue inflammation resolves.

ESR (Sedimentation Rate) & Ferritin

Day 0 + Wk 6–8

Why track at baseline: Tracks chronic connective-tissue and autoimmune/mucosal inflammatory activity alongside iron stores.

Week 6–8 check: Downward trend in ESR confirming structural resolution rather than temporary analgesic masking.

CBC with Differential (WBC, Neutrophil/Lymphocyte Ratio)

Day 0 + Wk 6–8

Why track at baseline: Evaluates innate/adaptive immune balance (especially for Thymosin Alpha-1, Thymosin Beta-4, LL-37 & KPV).

Week 6–8 check: Balanced lymphocyte count and improved Neutrophil-to-Lymphocyte Ratio (NLR 1.2–2.0).

CMP (Liver/Kidney) + Serum Copper & Zinc Ratio

Day 0 + Wk 6–8

Why track at baseline: Verifies baseline hepatic/renal function and checks Copper:Zinc balance before GHK-Cu / GLOW / KLOW protocols.

Week 6–8 check: Maintain 1:1 to 1.2:1 Zinc-to-Copper equilibrium and normal transaminases/creatinine.

Test before and during your protocol: one baseline panel of 100+ Quest biomarkers covering the markers above, plus a mid-cycle retest. No doctor visit required.Code SPAMBASSADOR
Get baseline bloodwork at Superpower

Related Studies

10 Human10 Animal

Although preclinical studies are promising, there is a current lack of clinical trials. This review integrates current mechanistic insights with orthopaedic relevance, emphasizing safety, efficacy, and future directions for responsible integration into musculoskeletal care.

Limitations: No placebo control reported. Review article — no new primary data.

2026|Journal of the American Academy of Orthopaedic Surgeons. Global research &amp; reviews
PubMed

Moreover, despite the considerable volume of research on the biological and pharmacodynamic characteristics of Epitalon, the quantity of physico-chemical and structural investigations of this peptide remains quite limited. This review aims to conclude the most important findings from such studies, thus presenting the current state of knowledge on Epitalon.

Limitations: No placebo control reported. Review article — no new primary data.

2025|International journal of molecular sciences
PubMed

Only a minor increase in ALT activity was observed in Normal cells, thereby showing that it was specific to cancer cells. Our data suggests that epitalon can extend telomere length in normal healthy mammalian cells through the upregulation of hTERT mRNA expression and telomerase enzyme activity.

Limitations: No placebo control reported.

2025|Biogerontology
PubMed

More mechanistic investigations are needed to confirm Epitalon's benefits and safety. Developing ophthalmic forms of Epitalon may enhance its delivery directly to the retina, potentially improving its therapeutic efficacy.

Limitations: No placebo control reported.

2025|Stem cell reviews and reports
PubMed

Epitalon treatment significantly decreased frequency of spindle defects and abnormal distribution of cortical granules during aging for 12h and 24h, while increased mitochondrial membrane potential and DNA copy number of mitochondria, thus decreasing apoptosis of oocytes by 24h of in vitro aging. Our results suggest that Epitalon can delay the aging process of oocytes in vitro via modulating mitochondrial activity and ROS levels.

Limitations: Animal study only — human translation uncertain.

2022|Aging
PubMed

AEDG peptide and histones H1/3, H1/6 binding may be one of the mechanisms which provides an increase of Nestin, GAP43, &#x3b2; Tubulin III, and Doublecortin neuronal differentiation gene transcription. AEDG peptide can epigenetically regulate neuronal differentiation gene expression and protein synthesis in human stem cells.

Limitations: No placebo control reported.

2020|Molecules (Basel, Switzerland)
PubMed

AEDG and KED peptides could be used as supplementary substances in a culture medium to delay the expression of senescence markers in long term stem cell cultivation in order to promote the large-scale in vitro expansion necessarily required for stem cell therapy clinical application. The data obtained confirm the geroprotective effect of AEDG and KED peptide, which was shown early in animal and cells models.

Limitations: Standard limitations apply. Check original paper for full discussion.

2020|Stem cell reviews and reports
PubMed

&#x41a;&#x440;&#x43e;&#x43c;&#x435; &#x442;&#x43e;&#x433;&#x43e;, &#x443; &#x43b;&#x44e;&#x434;&#x435;&#x439; &#x441;&#x43e; &#x441;&#x43d;&#x438;&#x436;&#x435;&#x43d;&#x43d;&#x43e;&#x439; &#x43c;&#x435;&#x43b;&#x430;&#x442;&#x43e;&#x43d;&#x438;&#x43d;&#x43e;&#x431;&#x440;&#x430;&#x437;&#x443;&#x44e;&#x449;&#x435;&#x439; &#x444;&#x443;&#x43d;&#x43a;&#x446;&#x438;&#x435;&#x439; &#x44d;&#x43f;&#x438;&#x444;&#x438;&#x437;&#x430;, &#x43f;&#x435;&#x43f;&#x442;&#x438;&#x434; AEDG &#x43d;&#x43e;&#x440;&#x43c;&#x430;&#x43b;&#x438;&#x437;&#x443;&#x435;&#x442; &#x43f;&#x43e;&#x432;&#x44b;&#x448;&#x435;&#x43d;&#x43d;&#x443;&#x44e; &#x44d;&#x43a;&#x441;&#x43f;&#x440;&#x435;&#x441;&#x441;&#x438;&#x44e; &#x446;&#x438;&#x440;&#x43a;&#x430;&#x434;&#x43d;&#x44b;&#x445; &#x433;&#x435;&#x43d;&#x43e;&#x432; Clock &#x438; Csnk1e &#x432; &#x43b;&#x435;&#x439;&#x43a;&#x43e;&#x446;&#x438;&#x442;&#x430;&#x445; &#x438; &#x432; 2 &#x440;&#x430;&#x437;&#x430; &#x43f;&#x43e;&#x432;&#x44b;&#x448;&#x430;&#x435;&#x442; &#x441;&#x43d;&#x438;&#x436;&#x435;&#x43d;&#x43d;&#x443;&#x44e; &#x44d;&#x43a;&#x441;&#x43f;&#x440;&#x435;&#x441;&#x441;&#x438;&#x44e; &#x433;&#x435;&#x43d;&#x430; Cry2 &#x432; &#x43b;&#x438;&#x43c;&#x444;&#x43e;&#x446;&#x438;&#x442;&#x430;&#x445; &#x43a;&#x440;&#x43e;&#x432;&#x438;. &#x412; &#x43e;&#x441;&#x43d;&#x43e;&#x432;&#x435; &#x433;&#x435;&#x440;&#x43e;&#x43f;&#x440;&#x43e;&#x442;&#x435;&#x43a;&#x442;&#x43e;&#x440;&#x43d;&#x43e;&#x433;&#x43e; &#x44d;&#x444;&#x444;&#x435;&#x43a;&#x442;&#x430; &#x43f;&#x435;&#x43f;&#x442;&#x438;&#x434;&#x430; AEDG &#x43b;&#x435;&#x436;&#x438;&#x442; &#x435;&#x433;&#x43e; &#x441;&#x43f;&#x43e;&#x441;&#x43e;&#x431;&#x43d;&#x43e;&#x441;&#x442;&#x44c; &#x432;&#x43e;&#x441;&#x441;&#x442;&#x430;&#x43d;&#x430;&#x432;&#x43b;&#x438;&#x432;&#x430;&#x442;&#x44c; &#x43c;&#x435;&#x43b;&#x430;&#x442;&#x43e;&#x43d;&#x438;&#x43d;&#x43e;&#x431;&#x440;&#x430;&#x437;&#x443;&#x44e;&#x449;&#x443;&#x44e; &#x444;&#x443;&#x43d;&#x43a;&#x446;&#x438;&#x44e; &#x44d;&#x43f;&#x438;&#x444;&#x438;&#x437;&#x430; &#x447;&#x435;&#x440;&#x435;&#x437; &#x440;&#x435;&#x433;&#x443;&#x43b;&#x44f;&#x446;&#x438;&#x44e; &#x44d;&#x43a;&#x441;&#x43f;&#x440;&#x435;&#x441;&#x441;&#x438;&#x438; &#x447;&#x430;&#x441;&#x43e;&#x432;&#x44b;&#x445; &#x433;&#x435;&#x43d;&#x43e;&#x432; &#x447;&#x435;&#x43b;&#x43e;&#x432;&#x435;&#x43a;&#x430;.

Limitations: No placebo control reported.

2020|Advances in gerontology = Uspekhi gerontologii
PubMed

Treatment with Epitalon slowed down the development of metastases from spontaneous tumors, and no metastases were found in the experimental mice. These data highlight the antimetastatic effect of Epitalon as part of its oncostatic properties.

Limitations: Animal study only — human translation uncertain.

2006|In vivo (Athens, Greece)
PubMed

According this theory, ageing is an evolutionary determined biological process of changes in gene expression resulting in impaired synthesis of regulatory and tissue-specific peptides in organs and tissues, which provokes their structural and functional changes and the development of diseases. Correspondingly, correction of such disorders by means of stimulation of peptide production in the organism or through their delivery can promote the normalisation of disturbed body functions.

Limitations: No placebo control reported. Review article — no new primary data.

2003|Neuro endocrinology letters
PubMed

Epithalon alone or in combination with Vilon activated expression of 194 clones (maximally by 6.61 times) and inhibited expression of 48 clones (maximally by 2.71 times). Our results demonstrate the specific effects of Epithalon and Vilon on gene expression.

Limitations: Animal study only — human translation uncertain.

2003|Bulletin of experimental biology and medicine
PubMed

We registered a 4.1-fold mortality decrease in this group as compared to the control level. The results of our research confirmed the conclusion on the high geroprotective efficacy of Thymalin and Epithalamin and the expediency of their application in medicine and social care as the means of health maintenance and age-related pathology prevention in persons over 60 years old enabling the prolongation of the active period of their lives.

Limitations: Review article — no new primary data.

2003|Advances in gerontology = Uspekhi gerontologii
PubMed

Epithalon prolonged the lifetime of mice with breast tumors by 1.4 times (p<0.05). These results indicate that Epithalon possesses geroprotective activity and inhibits breast carcinogenesis in transgenic mice, which is probably related to suppression of HER-2/neu expression.

Limitations: Animal study only — human translation uncertain.

2003|Bulletin of experimental biology and medicine
PubMed

A uniting aspect of such a range of activities might be the participation of transcription factors, since they are often highly conservative in evolution and, on the other hand, may be strictly tissue-specific. The targets of Epithalon may include transfactors that in mammals are specific for the pineal gland and retina and exhibit impaired functions in the aged pineal gland.

Limitations: Animal study only — human translation uncertain.

2002|Advances in gerontology = Uspekhi gerontologii
PubMed

The expression of mRNA for HER-2/neu was also partially reduced in Vilon-treated mice, but it remained significantly higher in Vilon- than in Epitalon-treated animals (1.9-fold increase). The data demonstrate the inhibitory effect of Epitalon in the development of spontaneous mammary tumors in HER-2/neu mice, suggesting that a downregulation of HER-2/neu gene expression in mammary adenocarcinoma may be responsible, at least in part, for the antitumor effect of the peptide.

Limitations: Animal study only — human translation uncertain.

2002|International journal of cancer
PubMed

Epitalon inhibited also the development of tumors in jejunum and ileum. Thus, our results demonstrated an inhibitory effect of Epitalon on chemically induced bowel carcinogenesis in rats.

Limitations: Animal study only — human translation uncertain.

2002|Cancer letters
PubMed

These findings confirm the data on functional relationships between the pineal gland and immune system. The effects of epithalamin and epithalon on cell and tissue homeostasis in the spleen of old pinealectomized rats can be regarded as a manifestation of the general regulatory effect of these peptides.

Limitations: Animal study only — human translation uncertain.

2002|Bulletin of experimental biology and medicine
PubMed

The activity of Cu, Zn-superoxide dismutase (SOD) was found decreased in the brain of aged rats (30 months old) by 46.8% as compared to young animals. Concentration of Schiff's bases in the brain also went down with age (by 13.6%), while the level of dien conjugates (DC) and protein peroxidation (PPO) remained unchanged.

Limitations: No placebo control reported. Review article — no new primary data.

2001|Neuro endocrinology letters
PubMed

It has been shown that epithalamin increased synthesis and secretion of melatonin in rats and inhibits free radical processes in rats and in D. It is suggested that antioxidative properties of epithalamin lead to increased lifespan of three different animal species.

Limitations: Animal study only — human translation uncertain.

1998|Mechanisms of ageing and development
PubMed

Twenty years of study on effects of pineal peptide preparation: epithalamin in experimental gerontology and oncology. (Annals of the New York Academy of Sciences, 1994)

Limitations: Animal study only — human translation uncertain. Review article — no new primary data.

1994|Annals of the New York Academy of Sciences
PubMed

Community Outcomes

Community Data Coming Soon

Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!

Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.

Important Warnings

  • •Limited human clinical trials
  • •Long-term effects unknown
  • •Most studies are in animals or cell cultures
Sourcing, Diagnostic Bloodwork & Telehealth Pathways

Where to get Epitalon (Epithalon), baseline labs & clinician oversight.

Full Epitalon (Epithalon) $/mg comparison →
50% OFF AUTO-APPLIED$2.50/mg net

Ascension Peptides (US Vials)

MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.

MZ Biolabs COA (Grade A)Claim 50% Off
Verified Vial SuppliersGrade A COA

SwissChems & Limitless Biotech

Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).

LABS & 503A CLINICS$199/yr Labs · Rx Consult

Superpower Labs & 503A Telehealth

Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.

Code:SPAMBASSADOR

Where to buy Epitalon (Epithalon): best verified price

Prices checked Nov 11, 2026 · sorted by $/mg · RUO

  1. 1. Swift Peptides — $1.98/mg (50mg vial, $98.99)
  2. 2. Bulletproof BioLabs — $2.10/mg (50mg vial, $105.00)
  3. 3. Ascension Peptides — $2.50/mg (10mg Lyophilized Vial, $25.00)

Where is the cheapest place to buy Epitalon (Epithalon)?

As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Swift Peptides at $1.98/mg (50mg vial, $98.99). We compared 10 US suppliers with live, checked prices.

How much does Epitalon (Epithalon) cost per mg?

Verified US domestic prices currently range from $1.98/mg to $7.50/mg depending on supplier and vial size. Larger vials usually lower the $/mg.

How are these prices verified?

Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.

Is Epitalon (Epithalon) approved for human use?

Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.

All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet

FREE 1-PAGE PDF CHEAT SHEET

Peptide Reconstitution & U-100 Syringe Cheat Sheet

Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.

Unsubscribe anytime.Direct PDF Download

Related Peptides

Popular Stacks

Vendor vs vendor: price per mg

Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.

Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →

Common questions

How many peptides are in the database?

100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.

Where can I compare peptide prices?

Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.